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Background In epidemiologic research, little emphasis has been placed on meth-
ods to account for left-hand censoring of ‘exposures’ due to a limit
of detection (LOD).
Methods We calculate the odds of anti-HIV therapy naiveté in 45 HIV-
infected men as a function of measured log10 plasma HIV RNA
viral load using five approaches including ad hoc methods as well
as a maximum likelihood estimate (MLE). We also generated simu-
lations of a binary outcome with 10% incidence and a 1.5-fold
increased odds per log increase in a log-normally distributed expo-
sure with 25, 50 and 75% of exposure data below LOD. Simulated
data were analysed using the same five methods, as well as the
full data.
Results In the example, the estimated odds ratio (OR) varied by 1.22-fold
across methods, from 1.45 to 1.77 per log10 copies of viral load and
the standard error for the log OR varied by 1.52-fold across meth-
ods, from 0.31 to 0.47. In the simulations, use of full data or the
MLE was unbiased with appropriate confidence interval (CI) cover-
age. However, as the proportion of exposure below LOD increased,
substituting LOD, LOD/ˇ2 or LOD/2 was increasingly biased with
increasingly inappropriate CI coverage. Finally, exclusion of values
below LOD was unbiased but imprecise.
Conclusions In this example and the settings explored by simulation, and
among methods readily available to investigators (i.e. sans full
data), the MLE provided an unbiased and appropriately precise
estimate of the exposure–outcome OR.
Keywords Biomarkers, epidemiologic methods, limit of detection, statistical
method
Introduction
In epidemiologic research, emphasis is placed rightly
on appropriately accounting for incomplete outcome
data due to censoring.1 For example, methods are
commonly employed to account for right-hand cen-
soring of times-to-event due to drop-out or study
completion. In addition, analyses of biomarker out-
comes due to a limit of detection (LOD) commonly
employ methods (for possible mixtures of true
zeros) and left-hand censoring at the LOD.2–10
However, with few exceptions,11–15 little emphasis
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has been placed on principled methods to account for
left-hand censoring of biomarker exposures due to
an LOD.
The LOD is the lowest quantity of a substance that
can be distinguished from the absence of the sub-
stance. Most analytic instruments produce a signal
even when a matrix without the analyte (i.e. a
blank) is analysed. The LOD is often estimated as
the mean of the blank plus the product of a confi-
dence level (e.g. 99%) and the standard deviation
(SD) of the blank. Values below the LOD may
indeed be useful (albeit perhaps subject to more mea-
surement error than values above the LOD), but here
we assume that such values are not reported by the
laboratory, as is common practice.
We compare the use of several ad hoc methods to
account for an exposure with an LOD when estimat-
ing the odds ratio (OR). In particular, we describe an
example of estimating the odds of anti-HIV therapy
naiveté in HIV-infected men as a function of the
plasma HIV RNA viral load. In addition, we describe
moderate- and large-sample simulation experiments




As an example, we calculate the odds of anti-HIV
therapy naiveté in 45 HIV-infected heterosexual men
as a function of the log10 plasma HIV RNA viral load.
The 45 HIV-infected men have been previously
described.16 Briefly, viral load was ascertained from
plasma samples using RNA amplification yielding an
LOD of 400 copies/ml of plasma. History of anti-HIV
therapy use was obtained by self-report. Identification
of particular agents or therapy regimens by self-report
may be subject to substantial misclassification, but
classification of having ever used any anti-HIV ther-
apy by self-report is likely subject to substantially less
misclassification.
Due to the established effectiveness of anti-HIV
therapies,2,17 one would surmise a priori that a high
level of viral load would suggest that a patient with
established HIV is therapy naı̈ve, although patients
receiving anti-HIV therapies that fail or patients that
are not adherent may also demonstrate high levels of
viral load.
Statistical methods
Data were analysed with logistic regression for the
binary outcome therapy naiveté with the log10 HIV
RNA viral load exposure as the sole covariate using
five approaches. First, records with values of expo-
sure below the LOD were excluded from analysis.
Secondly, the LOD was substituted for exposure
values below the LOD. Thirdly, the LOD/ˇ2 was sub-
stituted for exposure values below the LOD. Fourthly,
the LOD/2 was substituted for exposure values below
the LOD. Lastly, a maximum likelihood estimate (MLE)
was obtained as described in the following paragraph.
One can find the MLE accounting for an LOD in the
exposure. Although the likelihood function has no
closed form, it can be expressed through an 1D inte-
gral. As is standard with maximum likelihood,18 given
the correct data generating mechanism, the estimates
are asymptotically unbiased and efficient. The log
likelihood is
log L ¼ y log pð Þ  1 ð Þ þ 1 yð Þ  log 1 pð Þ
 1 ð Þ þ log f xð Þ½   1 ð Þ þ log qð Þ  ,
where y is an indicator of the event of interest,
p ¼ 1=f1þ exp½ð0 þ 1 logðxÞÞg,  is an indicator of
exposure x  LOD,
















y 1 pð Þ1yf xð Þdx. This integral must be eval-
uated numerically. We do so by a Riemann sum,
which can approximate q to a chosen level of accu-
racy. SAS code is provided in Appendix 1, using the
NLMIXED procedure to maximize this log likelihood.
R code is provided in Appendix 2, using the optim()
function to maximize this log likelihood.
Monte Carlo simulation
Six scenarios were studied varying the sample size as
moderate (N¼ 500) or large (N¼ 2000) and the per-
cent of exposure below the LOD as 25, 50 or 75%.
Undetectable percentages as large as 50% may be
seen in epidemiologic research on novel biomarkers
before great strides are made in the refinement of
the assay or measurement. For example, in the mid-
1990s, when effective therapies for HIV debuted
assays for HIV RNA viral load were still in early
stages of refinement and often provided large percen-
tages of undetectable measurements for successfully
treated individuals. Whereas we would rarely expect
to see biomarkers with 75% below the LOD, this sce-
nario is studied to provide a more complete picture.
For each scenario, 5000 simulations were generated.
For each simulated subject, a log-normally distribu-
ted exposure, X, was generated to have a median of
1 and first and third quartiles of 0.5 and 2.0, respec-
tively. Limits of detection were set at 0.5, 1 and 2 to
achieve the desired percents below the LOD. To reflect
typical epidemiologic studies, a binary outcome was
generated with a marginal incidence of 10%, condi-
tional on the log-normal exposure with an OR of 1.5,
which yielded 75 and 499% statistical power in the
moderate and large sample settings, respectively.
Simulated data were analysed with logistic regres-
sion for the binary outcome with the log-normal
exposure as the sole covariate using the same five
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approaches described for the example as well as the
full data. Full data were analysed using true values
for exposure below the LOD. This full data approach
is not typically available to investigators but is con-
ducted here to provide a reference.
Simulation results are tallied as: percent bias,
defined as 100 exp 1
 
=1:5 100, where 1 is the




b1,jÞ; Monte Carlo standard error





b1,j  1Þ2q ;
statistical power, defined as the percent of simula-
tions that produce a statistically significant result
given a true OR of 1.5, with a two-sided  of 0.05;
and confidence interval (CI) coverage, defined as the
percent of simulations where the 95% CI traps the
true OR. A separate simulation study was conducted
to assess the validity of the approaches (i.e. type 1
error) using the large sample size and 50% of expo-
sure below the LOD. The simulation standard error




Of 45 men, 23 were non-White and the median age
(inter-quartile range, IQR) was 40 (37–46) years. Of
45 men, 10 had infection duration 46 years and 1/3
had an existing AIDS diagnosis. Of 45, 10 had a viral
load below the LOD (of 400 copies/ml); among the 35
of 45 with a quantified viral load, the median number
of log10 copies (IQR) was 4.57 (3.68–5.04). The mean
log10 viral load was 4.41 and the skew was –0.36,
suggesting (given the limited sample size) a relatively
log-normal distribution. Of 45 men, 12 were therapy
naı̈ve by self-reports. Figure 1 provides the viral load
values by anti-HIV therapy naiveté status.
As shown in Table 1, the estimated OR of being
therapy naı̈ve for each log10 difference in viral load
ranged from 1.45 with the MLE to 1.77 with substi-
tution of the LOD. Exclusion and substitution of
LOD/2 yielded similar ORs of 1.54 (95% CI 0.61–
3.90) and 1.56 (95% CI 0.90–2.69), respectively.
Substitution of LOD and LOD/ˇ2 yielded larger ORs
of 1.77 (95% CI 0.88–3.56) and 1.64 (95% CI 0.90–
2.99), respectively. As expected given the simulation
results (see below), relative to the MLE, the ad hoc
substitutions provided estimates of the OR that
were 8–22% larger than the MLE, and therefore
likely biased away from the null in this setting.
Also, the ad hoc substitutions provided standard
errors that were 36–18% smaller than the MLE. These
smaller standard errors were likely overly optimistic
given that single deterministic substitutions do not
account for the uncertainty in the missing values
below the LOD.
Simulation results
As expected, across the six scenarios studied, the use
of full data provided an approximately unbiased
estimate of the OR with appropriate CI coverage
(Table 2). In addition, the MLE provided an unbiased
estimate with appropriate CI coverage in all scenarios.
The MLE, which accounts for the uncertainty in the
missing data, appropriately provided slightly less pre-
cision than the full data even when the proportion
below the LOD was only 25%. However, when the
proportion below the LOD was 75%, the MLE was
430% less efficient than the estimate obtained from
the full data. Exclusion of exposures below the LOD
was relatively unbiased, but sacrificed precision. For
instance, with 50% of exposure below the LOD, exclu-
sion resulted in standard errors approximately twice
as those of the full data and was therefore associated
with 75% efficiency loss. Substitution of LOD,
LOD/ˇ2 or LOD/2 provided estimates of the OR that
were increasingly biased as the percent of exposure
Figure 1 Distribution of HIV RNA viral load by anti-HIV
therapy naiveté in 45 HIV-infected men. Overlapping values
are stacked so that all observations are visible
Table 1 OR of anti-HIV therapy naiveté in 45 HIV-infected
men for competing ad hoc methods to account for a log10








1. Exclude <LOD 1.54 0.47 0.61–3.90
2. Substitute LOD 1.77 0.36 0.88–3.56
3. Substitute LOD/ˇ2 1.64 0.31 0.90–2.99
4. Substitute LOD/2 1.56 0.28 0.90–2.69
5. MLE 1.45 0.44 0.61–3.44
1676 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
below the LOD increased. Also, substitution of LOD,
LOD/ˇ2 or LOD/2 provided inadequate CI coverage,
which was more apparent in the large sample
(N¼ 2000) scenarios. For instance, with 75% of expo-
sure below the LOD and N¼ 2000, substitution of
LOD, LOD/ˇ2 or LOD/2 provided subpar 54, 69 and
88% CI coverage, respectively. Under the null, the
following type 1 errors were obtained for full data,
excluding exposure below the LOD, substituting
LOD, LOD/ˇ2, LOD/2, and the MLE: 5.0, 4.9, 5.0,
4.9, 4.6 and 4.7%, respectively. All estimated type 1
errors were within two simulation standard errors of
the expected 5%.
Discussion
We demonstrated that many common ad hoc methods
to account for an LOD in an exposure variable are
flawed. Use of the MLE appeared unbiased, appropri-
ately precise (relative to the full data) and provided
appropriate CI coverage and type 1 error. While exclu-
sion of exposures below the LOD was unbiased, it was
only unbiased in these settings because the effect of
exposure on outcome was constant across the range
of exposure.19 Moreover, a great loss in precision may
accompany exclusion of values below the LOD: a por-
tion of this information may be recovered using the
MLE. The example analysis supported simulation
results, but is based on a small study of 45 HIV-
infected men.
Existing work on left- or interval-censored expo-
sures is scarce. Lynn11 compared several ad hoc sub-
stitutions, a maximum likelihood approach and
several multiple-imputation approaches using the
example of left-censored HIV viral load as an expo-
sure for incident AIDS as well as simulations. Lynn
found the maximum likelihood approach operated
best (i.e. smallest mean squared error). Gomez
et al.13 derived MLEs for a discrete-valued interval-
censored baseline characteristic in a randomized trial,
and demonstrated by simulation that midpoint
substitution is flawed. Richardson and Ciampi12 dis-
cussed the setting where a left-censored exposure
is subject to measurement error, they suggested sub-
stitution of the expectation below the LOD will
provide unbiased estimates and they describe simula-
tions demonstrating that standard results for non-
differential, independent measurement error may
not apply in the presence of a left-censored exposure.
Schisterman et al.14 developed a substitution method
for handling left-censored exposures in linear and
logistic regression with a nutritional biomarker exam-
ple and simulations: the authors concluded that repla-
cing values below the LOD with the expectation
‘above’ the LOD provided unbiased estimates while
overcoming the distributional assumptions of other
methods. Lei et al.15 provided a likelihood-based
framework that incorporates the approaches of
Richardson and Ciampi12 and Schisterman et al.14
Table 2 Simulations comparing ad hoc methods to account












Exclude <LOD 1 0.219 48 95
Substitute LOD 5 0.176 72 95
Substitute LOD/ˇ2 2 0.165 73 96
Substitute LOD/2 1 0.155 73 95
MLE 1 0.159 74 95
Full data 0 0.157 74 95
N¼ 2000
Exclude <LOD 0 0.105 96 95
Substitute LOD 5 0.087 99 91
Substitute LOD/ˇ2 2 0.082 99 94
Substitute LOD/2 1 0.077 99 94
MLE 0 0.080 99 95
Full data 0 0.078 99 95
50% <LOD
N¼ 500
Exclude <LOD 1 0.321 29 95
Substitute LOD 15 0.227 68 90
Substitute LOD/ˇ2 8 0.194 71 93
Substitute LOD/2 1 0.169 71 95
MLE 0 0.168 68 96
Full data 1 0.159 76 95
N¼ 2000
Exclude <LOD 0 0.151 77 95
Substitute LOD 15 0.110 99 75
Substitute LOD/ˇ2 7 0.095 99 88
Substitute LOD/2 1 0.083 99 95
MLE 0 0.085 99 95
Full data 0 0.078 99 95
75% <LOD
N¼ 500
Exclude <LOD 3 0.561 14 96
Substitute LOD 33 0.356 55 84
Substitute LOD/ˇ2 19 0.273 60 89
Substitute LOD/2 7 0.219 61 94
MLE 0 0.193 59 95
Full data 0 0.156 75 95
N¼ 2000
Exclude <LOD 1 0.247 38 96
Substitute LOD 36 0.165 98 54
Substitute LOD/ˇ2 20 0.129 99 69
Substitute LOD/2 8 0.105 99 88
MLE 0 0.094 99 95
Full data 0 0.079 99 95
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for linear regression, as well as simulations and two
worked examples: the authors conclude that the like-
lihood-based approach is optimal, albeit subject to
distributional assumptions.
In addition to accounting for an LOD by the use of
methods for left-censored observations, one may con-
sider a proportion of the values below the LOD to be
true zeros. Methods that allow the exposure to be a
mixture of true zeros and continuous values, possibly
left-censored by an LOD, may be more appropriate in
such settings. Approaches have been developed for
outcomes,6,10 but to our knowledge not for exposures.
Alternatively, as proposed by Schisterman et al. in
the receiver operating characteristic curve context,20,21
one could fit the analogy of a two-part model, such as
a binary indicator for being below the LOD and a
continuous regressor for values above the LOD. In
such extensions, as in the approach described
here, the choice of parametric distribution for expo-
sure values (or values above 0 or the LOD in the mix-
ture or two-part model, respectively) is crucial.
Therefore, thorough exploratory data analysis and
information from subject-matter specialists are
essential.
One can envision the ad hoc solutions studied, e.g.
substitution of LOD/2, LOD/ˇ2 and the LOD itself as
points along a continuum of possible values for the
left-censored exposures. Therefore, it is reasonable
that the bias is a function of the substituted value.
Indeed, if one were able to plug-in the expectation of
exposure below the LOD for values below LOD,
the resultant estimate would be approximately
unbiased.12 However, in practice, one will not typi-
cally know the expectation of exposure below the
LOD and therefore not be able to simply calibrate
the substitution value to remove bias (although once
a parametric form is specified for the likelihood, one
could calculate this expectation in principle). Even if
one were able to simply calibrate such a substitution,
the resultant interval estimate would be overly precise
due to not accounting for the uncertainty in the
calibration.
However, it should be noted that substitution of the
LOD/2 worked fairly well in simulations with 450%
exposure data below the LOD. This is the case here
because the expectation of exposure below the LOD
(SD) was 0.3 (0.12), 0.5 (0.25) and 0.8 (0.5) for 25,
50 and 75% of exposure below the LOD, respectively.
Therefore, at an LOD of 0.5, and of the substitutions
explored, LOD/ˇ2¼ 0.35 will best mimic the expecta-
tion below the LOD; at an LOD of 1, substitution of
LOD/2¼ 0.5 will best mimic the expectation below the
LOD; and at an LOD of 2, substitution of LOD/
2.5¼ 0.8 (not explored) would have best mimicked
the expectation below the LOD.
Whereas these simulations typified data seen in epi-
demiologic research (albeit enriching the percent
below the LOD), more empirical examples are war-
ranted. A limitation of maximum likelihood is its pos-
sible sensitivity to incorrect specification of the model
for the data: this in particular could be explored in
future work. In addition to maximum likelihood,
multiple-imputation22 and Bayesian23 methods
should also be explored in more detail. Indeed,
multiple-imputation provides MLEs when data are
missing at random and the imputation model form
is correct.22 However, it should be noted that simply
multiplying imputing values from a uniform distribu-
tion below the LOD will only provide unbiased results
if the uniform distribution correctly reflects the distri-
bution of biomarker values below the LOD, which is
unlikely in epidemiologic settings. In conclusion,
in the settings explored and among methods typi-
cally available to investigators (i.e. sans full data
or substitution of expectation of exposure below the
LOD), many ad hoc approaches to handling exposures
subject to an LOD are flawed. However, maximum
likelihood provides an unbiased and appropri-
ately precise estimate of the exposure–outcome
association.
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KEY MESSAGES
 Little emphasis has been placed on principled methods to account for left-hand censoring of
biomarker exposures due to a limit of detection (LOD).
 Ad hoc methods to account for an exposure LOD are flawed.
 Maximum likelihood methods are unbiased and appropriately precise.
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Appendix 1
SAS code for the MLE
proc nlmixed;
parms b0=0 b1=0 c0=1 c1=1;
p=1/(1 + exp(-(b0+b1*log(x))));
q=0;
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